|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Grant revenue | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Change in fair value of embedded derivative liability | ||
| Loss on extinguishment of convertible promissory note | ||
| Interest and other expense | ||
| Interest and other | ||
| Total other expense | ||
| Net loss | ||
| Net loss per share, basic and diluted | ||
| Other comprehensive loss: | ||
| Unrealized losses on available-for-sale debt securities | ||
| Comprehensive loss | ||
| Net loss per share, basic | ||
| Net loss per share, diluted | ||
| Weighted-average common shares outstanding, basic and diluted |
Loading...
